Oppenheimer Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,981
Closed -$203K 1210
2024
Q4
$203K Sell
3,981
-1,727
-30% -$84.9K ﹤0.01% 1082
2024
Q3
$235K Sell
5,708
-100
-2% -$4.8K ﹤0.01% 1053
2024
Q2
$280K Sell
5,808
-12
-0.2% -$532 ﹤0.01% 993
2024
Q1
$279K Sell
5,820
-76
-1% -$4.06K ﹤0.01% 972
2023
Q4
$383K Sell
5,896
-805
-12% -$48.5K 0.01% 925
2023
Q3
$438K Buy
6,701
+2,393
+56% +$151K 0.01% 883
2023
Q2
$250K Sell
4,308
-108
-2% -$6.81K ﹤0.01% 1009
2023
Q1
$273K Buy
4,416
+700
+19% +$42K ﹤0.01% 984
2022
Q4
$236K Sell
3,716
-1,658
-31% -$120K ﹤0.01% 1031
2022
Q3
$390K Sell
5,374
-106
-2% -$7.89K 0.01% 892
2022
Q2
$373K Sell
5,480
-171
-3% -$12.3K 0.01% 928
2022
Q1
$512K Sell
5,651
-160
-3% -$13.1K 0.01% 911
2021
Q4
$530K Sell
5,811
-213
-4% -$18.3K 0.01% 944
2021
Q3
$489K Sell
6,024
-163
-3% -$13.7K 0.01% 942
2021
Q2
$577K Sell
6,187
-86
-1% -$8.34K 0.01% 910
2021
Q1
$671K Sell
6,273
-229
-4% -$23.8K 0.01% 839
2020
Q4
$568K Buy
+6,502
New +$459K 0.01% 845

Other funds holding NARI

Oppenheimer Asset Management's NARI Position: Q1 2025 in Review

Oppenheimer Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 3,981 shares — an estimated $203K sold.

Oppenheimer Asset Management first reported a position in NARI in Q4 2020 and held it in 17 quarters. The position peaked at $671K in Q1 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Oppenheimer Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Oppenheimer Asset Management sold 3,981 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $203K.
  • Oppenheimer Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
  • Oppenheimer Asset Management's Inari Medical, Inc. Common Stock position peaked at $671K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Oppenheimer Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.